| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Nuclear Medicine, Cleveland Clinic Foundation, Cleaveland, Ohio
Correspondence: For correspondence or reprints contact: Eric Q. Chen, PhD, Dept. of Nuclear Medicine/Gb 3, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195.
ABSTRACT
Multidetector SPECT systems equipped with a high-energy, or 511-keV collimator, have been proposed to offer a less expensive alternative to PET in myocardial viability studies with [18F]FDG. The objectives of this investigation included: (a) measuring the physical imaging characteristics of SPECT systems equipped with either a high-energy general-purpose collimator (HE), or the dedicated 511-keV collimator (UH), when imaging 511-keV photons, and comparing them with conventional FDG PET; and (b) directly and quantitatively comparing the diagnostic accuracy of SPECT, with either an UH or HE collimator, to that of PET in myocardial viability studies using 18F-FDG. Methods: Physical imaging characteristics of SPECT and PET were measured and compared. Both SPECT and PET studies were performed in two groups of 18 patients each, with Group I using HE SPECT and Group II using UH SPECT. Myocardial perfusion studies were also performed using 82Rb PET at rest and during dipyridamole stress to identify areas of persistent hypoperfusion. For each myocardial region with a persistent perfusion defect, a perfusion-metabolism match or mismatch pattern was established independently, based on the results of 18F-FDG SPECT as well as PET. Results: PET is superior to SPECT in all physical imaging characteristics, particularly in sensitivity and contrast resolution. PET had a sensitivity 40–80 times higher than that of SPECT, and its contrast resolution was 40–100% better than SPECT. Between FDG-SPECT using an HE collimator and that using a 511-keV collimator, the latter showed marked reduction in septal penetration (from 56% to 38%), improvement in spatial resolution (from 17 mm to 11 mm FWHM) as well as contrast resolution (from 34% to 45%), while suffering reduced system sensitivity (from 75 to 34 cpm/µCi). Patient studies demonstrated that although FDG-SPECT, using a HE or UH collimator, provided concordant viability information as FDG PET in a large majority of myocardial segments with persistent perfusion defects (88% and 90%, respectively), there is an excellent statistical agreement (K = 0.736) between SPECT with UH collimator and PET, while the agreement between SPECT using HE collimator and PET are moderate (K = 0.413). Conclusion: Despite its markedly inferior physical imaging characteristics compared with PET, SPECT with the dedicated 511-keV collimator offers a low-cost, practical alternative to PET in studying myocardial viability using [18F]FDG. SPECT systems with a high-energy, general-purpose collimator, on the other hand, are inadequate in such studies.
Key Words: fluorine-18-FDG • SPECT • myocardial viability
This article has been cited by other articles:
|
|
 |
|
  A. F.L. Schinkel, D. Poldermans, V. Rizzello, R. T. van Domburg, R. Valkema, A. Elhendy, E. Biagini, E. P. Krenning, M. L. Simoons, and J. J. Bax Impact of Diabetes Mellitus on Prediction of Clinical Outcome After Coronary Revascularization by 18F-FDG SPECT in Patients with Ischemic Left Ventricular Dysfunction J. Nucl. Med., January 1, 2006; 47(1): 68 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F.L. Schinkel, J. J. Bax, R. Valkema, A. Elhendy, R. T. van Domburg, E. C. Vourvouri, M. A. Bountioukos, E. P. Krenning, J. R.T.C. Roelandt, and D. Poldermans Effect of Diabetes Mellitus on Myocardial 18F-FDG SPECT Using Acipimox for the Assessment of Myocardial Viability J. Nucl. Med., June 1, 2003; 44(6): 877 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Matsunari, T. Yoneyama, S. Kanayama, M. Matsudaira, K. Nakajima, J. Taki, S. G. Nekolla, N. Tonami, and K. Hisada Phantom Studies for Estimation of Defect Size on Cardiac 18F SPECT and PET: Implications for Myocardial Viability Assessment J. Nucl. Med., October 1, 2001; 42(10): 1579 - 1585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. V.R. Di Bella, D. J. Kadrmas, and P. E. Christian Feasibility of Dual-Isotope Coincidence/Single-Photon Imaging of the Myocardium J. Nucl. Med., June 1, 2001; 42(6): 944 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fukuchi, K. Hayashida, H. Moriwaki, K. Fukushima, N. Kume, T. Katafuchi, M. Sago, M. Takamiya, and Y. Ishida Brain Fluorine-18 Fluorodeoxyglucose Imaging with Dual-Head Coincidence Gamma Camera:Comparison with Dedicated Ring-Detector PositronEmission Tomography AJNR Am. J. Neuroradiol., January 1, 2000; 21(1): 99 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sato, T. Iwasaki, T. Toyama, Y. Kaneko, T. Inoue, K. Endo, and R. Nagai Prediction of Functional Recovery After Revascularization in Coronary Artery Disease Using 18F-FDG and 123I-BMIPP SPECT* Chest, January 1, 2000; 117(1): 65 - 72. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Mastin, W. E. Drane, E. M. Harman, J. J. Fenton, and L. Quesenberry FDG SPECT in Patients With Lung Masses Chest, April 1, 1999; 115(4): 1012 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Udelson Steps Forward in the Assessment of Myocardial Viability in Left Ventricular Dysfunction Circulation, March 10, 1998; 97(9): 833 - 838. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
